Abstract c-Cbl-associated protein
Introduction c-Cbl-associated protein (CAP), also identified as Sorbs1 (Sorbin and SH3 domain-containing protein 1) or ponsin, belongs to the SoHo vinexin family of adapter proteins. Together with nectin and afadin, CAP composes the cellcell adhesion system named NAP [22] . CAP interacts with several molecules, which modulate cell adhesion, cell migration, cytoskeleton, membrane trafficking, and intracellular signalling [17, 19, 47] . Remarkably, CAP has been described to be an essential adapter protein in the insulin-signalling pathway forming a complex with Cbl and flotillin, the latter being localized to the lipid raft of the cellular plasma membrane [5] . Structurally, CAP is localized with actin cytoskeleton, stress fibres, focal adhesion, cellcell adhesion structures, and has been also found in the cellular nucleus [18, 29, 46] . c-Cbl-associated protein is mainly expressed in heart, skeletal muscle, adipose tissue, and macrophages [19, 30] . Studies on a mouse model of high-fat diet-induced insulin resistance recently suggested a pro-inflammatory role for CAP. Accordingly, high-fat diet feeding increased proinflammatory cytokine and chemokine release from macrophages [19] . Despite the fact that a role of CAP in viral infection has not been described yet, these observations point toward a potential regulatory role of CAP in the innate immune system.
Together with Toll-like receptors TLR3, TLR4, TLR7, and TLR9, the PPR retinoic acid-induced gene I (RIG-I)-like receptors (RLRs) melanoma differentiation-associated protein 5 (MDA5) and RIG-I, identify virus particles and, in addition to NF-jB nuclear translocation, induce TBK1/ IKKe-dependent activation of interferon regulatory factors (IRFs) which results in the production of antiviral interferons (IFNs) [2, 16] . In particular, IRF3 plays a critical role in IFN-b production, while IRF7 regulates both IFN-a and IFN-b [15, 32] .
The Coxsackie virus B3 (CVB3), a cardiotropic positive single-strand RNA (?ssRNA) enterovirus, is an important cause of myocarditis, which often progresses to end-stage heart failure [31] . TLR3 and MDA5 recognize CVB3 double-strand RNA in the intracellular endolysosome or directly in the cytosol, respectively [2, 16, 44] . Another RLR helicase, RIG-I, recognizes negative single-strand RNA (-ssRNA) viruses such as the vesicular stomatitis virus (VSV) [16] . After infection, TLR3/MDA5-or TLR3/RIG-I-triggered type I IFNs on one side, and cytotoxic CD8
? T cells and NK cells eliminating virus-infected cells on the other side, limit virus expansion in the host [3, 11] . In the presence of severe infection, however, perforin-induced cytolysis may trigger extensive pro-apoptotic signalling pathways in heart tissue [3] . Extensive tissue damage together with a strong systemic inflammatory response, on the other hand, predisposes to heart-specific autoimmunity and heart failure progression [9] .
c-Cbl-associated protein has several functions and is highly expressed in the heart. Since a role for CAP in antiviral protection has not yet been elucidated, we aimed to clarify whether CAP may influence antiviral responses in cardiac diseases. To this end, we used a mouse model of Coxsackievirus-induced myocarditis to demonstrate the novel and beneficial dual role of CAP.
Results

CAP protects from CVB3-induced myocarditis
To clarify the in vivo role of CAP in viral heart disease, we infected CAP -/-mice and CAP ?/? littermate controls with CVB3 and analysed mortality, cardiac function, and myocarditis severity. In CAP ?/? mice, CAP was constitutively expressed at the RNA level before infection, decreased until day 4 after infection, and raised again until day 7 post infection (p.i.) (Fig. 1a) . Survival curve showed enhanced mortality in CAP -/-mice compared to CAP ?/? littermate controls in the first week of infection during acute myocarditis (Fig. 1b) Fig. S2c ). Similarly, we found more heart-infiltrating cytotoxic CD8 T and NK cells in CAP -/-compared to CAP ?/? mice after CVB3 infection (Fig. 1e, f) .
Lymphocytes activation and proliferation critically involve T cell receptor (TCR) downstream molecules such as the cytoplasmic signal transducer Lck and Zap-70 [38] . Phosphorylation of the Src family protein tyrosine kinase Lck at the regulatory tyrosine Y192, which in turn induces Zap-70 phosphorylation and amplifies TCR signal transduction and cytokines production [48] , was increased in CAP -/-splenocytes (Fig. 2c) .
Beside antiviral cytokines, Lck and the transmembrane receptor CAR directly determine CVB3 infectivity [21] . We therefore measured CAR and Lck in CVB3-infected hearts, and found that their expression was CAP independent (Suppl. Fig. S2d ). To better characterise T cell activation level, we measured the activation marker CD69. Consistently, we observed higher CD69 expression in CAP and CAP -/-heart cross sections. Right-pathological scores evaluating heart-infiltrating cells from score 0 to score 4 according to the range previously described [25] . Magnification 9200. d Cardiac function of mice at the baseline before CVB3 infection and 7 days after CVB3 infection was assessed by echocardiography (n = 7 each group). Left ventricular diameters were determined by transthoracic M-mode echocardiographic tracings. LV fractional shortening (FS) was calculated using the formula FS = [(LVEDD -LVESD)/ LVEDD] 9 100. e Flow cytometry analysis of heart-infiltrating cells of the innate immune system 4 days post infection. 
CD49b
? NK cells. Data are representative for two independent experiments (e-g), n = 5 each group (a-d) (mean, SD). *P \ 0.05, *P \ 0.01 (Student's t test) Interestingly, we measured comparable expression of co-stimulatory molecules CD40, CD80, and CD86, as well as MHCII, on antigen presenting CAP ?/? and CAP 
CD8
? T cell-and NK cell-induced cytotoxicity is largely mediated by perforin, which lyse virus-infected cells and eliminate the offending virus [11] . CAP inhibited expression and production of perforin in hearts and spleens after CVB3 infection and after in vitro stimulation (Fig. 2d, f) . Like perforin, granzyme B was similarly increased in hearts of CVB3-infected CAP -/-mice ( Fig. 2d ). Its expression in CVB3-infected spleens and in vitro-stimulated splenic cells, however, showed comparable levels between CAP
?/? and CAP -/- (Fig. 2d, g ). In line with increased cardiac infiltrations of CD8 T and NK cells in CVB3-infected CAP -/-mice, both virus titers and viral proliferation were reduced in hearts and spleens of CAP -/-mice 4 days after infection (Fig. 3a, b) . At day 10, however, plaque assays showed comparably low virus titers in hearts and spleens of both CAP -/-and CAP ?/? mice (Fig. 3a) .
Checking the typical cytokine expression patterns of activated primary T and NK cells in vitro, we observed that IL-17A, but not IFN-c, was higher in CAP -/-than in CAP ?/? splenic CD4 ? T cells, cytotoxic CD8 ? T, and NK cells (Suppl. Fig. S4a ). Beside its role in CD4
? Th1 lineage commitment, the transcription factor T-bet, as well as the transcription factor Eomes, also critically regulates the cytolytic effector mechanism of CD8
? T cells and NK cells [40] . In fact, we found significantly increased expression of T-bet and Eomes in spleens of CAP -/-mice 4 days after infection (Suppl. Fig. S4b, c) . In addition, and in accordance with higher IL-17A production in CAP -/-cells, the Th17 transcription factor RORc was highly expressed in CAP -/-mice (Suppl. Fig. S4b ). mice, we hypothesized that the increased cytotoxic response in the absence of CAP might promote activation of pro-apoptotic pathways in CAP -/-mice. To prove this hypothesis, we measured major pro-apoptotic molecules Bad and Cytochrome c in CVB3-infected hearts. Bad is inactive in its phosphorylated form, but when de-phosphorylated, contributes to Cytochrome c release from the mitochondria activating several caspases, which ultimately mediate apoptosis [8] . As expected, CAP -/-hearts showed lower levels of inactive, phosphorylated Bad (Fig. 3c) . Consistently, CAP -/-hearts expressed higher amounts of Cytochrome c compared to CAP ?/? hearts (Fig. 3c) . To test if enhanced apoptotic signals in CAP -/-mice were directly mediated through cytotoxic cells, we co-cultivated mouse neonatal cardiac fibroblasts (MNF) and NK cells in vitro. As observed in Fig. 3d and e, CAP -/-NK cells strongly inhibited viral proliferation on one side, but also promoted high levels of pro-apoptotic Cytochrome c release on the other side. It is know that the activation of the PI3K/Akt pathway modulates apoptosis. However, we excluded that the PI3K/Akt pathway determined apoptosis in the absence of CAP, since CVB3-infected mice did not show any difference between CAP ?/? and CAP -/-in phosphorylated PI3K and Akt in spleens and hearts (Suppl. Fig. S5a, b) .
CAP promotes type I IFNs production in vivo
So far, we provided evidence that CAP protects from virustriggered tissue damage and cytotoxicity in CVB3-mediated myocarditis. Efficient clearance of infective agents, however, had proven critical for host survival in the long term. We therefore asked how the CVB3-infected organism controls viral load while reducing the cytotoxic effect of CD8 T and NK cells. Given the importance of interferons during early antiviral defence, we therefore addressed whether and how CAP regulates type I and II IFNs. Accordingly, we measured RNA expression levels of type I and II IFNs, IRF3, and IRF7 in CAP ?/? and CAP -/-after CVB3 infection. RNA expression of all type I IFNs tested, hearts at day 4 p.i, and partially at day 10 p.i. compared to CAP -/-hearts, while IFN-c did not differ (Fig. 4a) . Similarly, IFN-a1 and IFN-b, but not IFN-a4 and IFN-c, were expressed at higher levels in CAP ?/? spleens compared to CAP -/-spleens at day 4 p.i. (Fig. 4b) . Enhanced RNA levels of the major type I IFNs transcription factors IRF3 and IRF7 in CAP ?/? hearts and spleens at day 4 post-CVB3 infection confirmed these results (Fig. 4c) . To test if CAP may influence type I IFN-dependent antiviral protection at the protein level, we collected blood serum from CVB3-infected mice at day 4. Consistent with the RNA expression data, analysis by ELISA showed that CAP ?/?
mice produced higher levels of IFN-b than CAP -/-mice (Fig. 4d) . In addition, phosphorylation of IRF3, which indicates IRF3 nuclear translocation and promotion of type I IFNs transcription, was increased in CAP ?/? hearts at day 4 post infection, while CAP -/-hearts showed only minimal IRF3 phosphorylation (Fig. 4e) .
MDA5, a cytosolic receptor recognizing CVB3 doublestrained RNA and triggering IRF3 phosphorylation [43] , is usually cleaved and degraded by CVB3 to limit type I IFNdependent host defence [4, 42] . We observed that CAP prevented MDA5 from degradation at the protein level in the heart after CVB3 infection (Fig. 4e) .
Taken together, CAP promotes type I IFN-dependent antiviral protection in acute CVB3-induced myocarditis.
CAP supports type I IFN-dependent antiviral protection in vitro
To test how CAP promotes type I IFNs production in vitro, we next stimulated MEF, BMDC, and BMM with ligands for TLR3 (PolyIC), TLR7 (R848), MDA5, and RIG-I and measured IFN-b and IFN-a1 induction. Since MDA5 and RIG-I are cytosolic RLRs helicases, we induced activation of MDA5 and RIG-I by transfecting cells with HMWPolyIC and LMW-PolyIC, respectively [27] . ELISA was used to analyse IFN-b at the protein level in supernatants, while IFN-b and IFN-a1 RNA levels were measured by qRT-PCR. We found that TRL3 and TLR7 ligands, as well as RIG-I, induced comparable amounts of IFN-b in both CAP ?/? and CAP -/-cells (Fig. 5a ), while MDA5 ligand induced higher levels of IFN-b in CAP ?/? cells than in their CAP -/-counterparts (Fig. 5b, c) . Similar to stimulation with HMW-PolyIC, which mimics viral (?)RNA ligands for MDA5, infection with CVB3 led to significantly higher levels of IFN-b in CAP ?/? BMDM compared to CAP -/-BMDC, while VSV infection, similar to LMWPolyIC, which mimics viral (-)RNA ligands for RIG-I, showed comparable IFN-b production in both cells (Fig. 5d, e) (Fig. 5c, d ). Similarly, comparable IFN-a1 over-expression was observed in CAP ?/? and CAP -/-BMDC and MEF after CVB3 or VSV infection (Fig. 5f, g ).
To figure out how CAP promotes type I IFNs production, we infected MEF with CVB3 and measured MDA5 and IRF3 protein expression. Indeed, MDA5 activation led to IRF3 phosphorylation and type I IFNs production [1] . As shown in Fig. 5h, MDA5 was properly expressed in the presence of CAP, while the absence of CAP was associated with a constant reduction of MDA5. Consequently, IRF3 phosphorylation was normal in infected CAP ?/? MEF, but not in their CAP -/-counterparts (Fig 5h) . These findings suggest that CAP is necessary for proper signalling transduction for type I IFNs production.
HeLa cells are suitable to study the function of CAP, since this cell line does not express endogenous CAP [47] . To figure out whether CAP reduces susceptibility to virus infections, we transfected HeLa cells with either a CAPexpressing vector or a mock vector as control. Transfected HeLa cells were then CVB3 infected and direct plaque assays were performed. As expected, CAP-transfected, but not mock-transfected HeLa cells, showed reduced viral proliferation (Fig. 5i, left) . Similarly, MEF were infected with CVB3 for 24 h and cell lysates were used to test viral proliferation by plaque assay. Similar to transfected HeLa cells, CVB3-infected CAP ?/? MEF showed lower viral proliferation compared to CAP -/-MEF (Fig. 5i, right) . Since CAP is highly expressed in the heart [19, 46] (Fig. 5j) . These results suggest that increased IFN-a1 and IFN-b expression observed in CAP ?/? hearts 4 days after CVB3 infection (Fig. 4a ) reflects enhanced production of IFN-a1 by cardiac cells on one side, and IFN-b production by heart-infiltrating dendritic cells and macrophages on the other side.
To figure out if increased IFN-a1 expression in CAP hand, reflects the presence of viral replication intermediates, corresponding to viral proliferation [20] . As shown in Fig. 5k , both CVB3 (?)RNA and (-)RNA strands were reduced in CAP ?/? MNC (Fig. 5k , top row) and MNF (Fig. 5k, bottom row) compared to their CAP -/-counterparts as early as 24 h after infection. Thus, CAP reduces CVB3 entry into cells as well as CVB3 replication. Mechanistically, the antiviral effect of CAP results from its role as a positive regulator of type I IFNs expression.
CAP supports MDA5 expression, while blocking MyD88
So far, we showed that CAP promotes type I IFN expression by enhanced phosphorylation of IRF3. However, the interaction between CAP and signalling molecules downstream of TLRs or RLRs receptors has not been investigated yet. To this end, we transfected HeLa cells with a CAP-encoding vector and infected them with CVB3. Immunoblotting of total cell lysates confirmed higher MDA5 expression before and after CVB3 infection in CAP-transfected cells compared to mock-transfected cells (Fig. 6a) . IRF3, MyD88, and p65 as well as general protein poly-and monoubiquitination were similar (Fig. 6a) . To analyse molecular interactions at different time points we immunoprecipitated FLAG-tagged CAP proteins. Looking at the most relevant proteins involved in CVB3-mediated type I IFNs production, we observed that MDA5 was the only molecule of the antiviral pathway, which interacted with CAP (Fig. 6b) . Our observations were confirmed by co-immunoprecipitation of MDA5 with CAP-FLAG (Fig. 6c) . Since relevant portions of the CAP protein, namely the SH3 sorbin domains, are needed to complex to the plasma membrane [5] , we evaluated MDA5 expression in HeLa cells transfected with FLAG-tagged CAP-wt or a FLAG-tagged CAP plasmid lacking of its SH3 domains (CAP-DSH3). Immunoprecipitation of FLAG-tagged CAP showed that the SH3 domains are necessary for CAP to complex with MDA5, but total cell lysates analysis confirmed that MDA5 expression was not dependent on SH3 domains of CAP (Fig. 6d) . Thus, CAP contributes to proper MDA5 expression.
In addition, we found that MyD88 was the only molecule of the NF-jB pathway, which complexed with CAP before CVB3 infection (Fig. 6b) . Since MyD88 ubiquitination induces MyD88 degradation, which then downregulates the pro-inflammatory MyD88-dependent NF-jB pathway [24] , we immunoprecipitated MyD88 and measured its ubiquitination. As hypothesized, MyD88 was ubiquitinated at a higher extent in CAP-transfected HeLa cells compared to mock-transfected HeLa cells after CVB3 infection (Fig. 6e) .
Taken together, our data suggest that binding of CAP to MyD88 results in ubiquitination and degradation of this adaptor molecule and consequently inhibition of the MyD88-dependent pro-inflammatory pathway.
Discussion
In the present study, we provide for the first time evidence for a regulatory role of CAP in innate antiviral immunity. In fact, we found a dual role of CAP in promoting antiviral type I IFNs production, while reducing cytotoxic responses. Moreover, we recognized that CAP is part of the MDA5 complex that specifically recognizes (?)ssRNA viruses, such as the myocarditis-inducing CVB3, but not (-)ssRNA viruses.
To fight viral infections, the host activates several immune mechanisms to limit viral proliferation. Fast and prompt migration of lymphoid cells of myeloid origin, such as dendritic cells and macrophages, are critical for initial viral clearance. These cells produce IRF3-, IRF5-, and IRF7-dependent antiviral IFNs after identifying genomic particles of invading RNA viruses [15, 32, 42] . We have recently described the protective role of early heart-infiltrating monocytes/macrophages expressing the chemokine receptor CCR5 within 2 days after CVB3 infection [42] . In parallel, host defence builds up CD8
? T and NK cellmediated responses to eliminate virus-infected cells. CD8 ? T and NK cells produce pore-forming perforin and granzymes that ultimately induce apoptosis of virus-infected cells [11] . Type I IFNs and cytotoxic proteins induce different antiviral responses. Indeed, type I IFNs, by binding to their receptors on the surface of dendritic cells and macrophages, promote the expression of IFN-stimulated genes (ISGs), such as Protein kinase R (PKR), 2 0 5 0 -oligoadenylate synthetase (OAS), Mx, viperin, and many others [28] . Co-ordinated activation of different ISGs can efficiently inhibit viral proliferation by blocking cell cycle of virus-infected cells, by preventing transport of incoming viral nucleocapsids into the cell nucleus, by interacting with viral capsids rendering virions non-infectious, or by inducing apoptosis of infected cells [28, 35] . Therefore, apoptosis induction in virus-infected cells is only one of several type I IFNs-mediated antiviral mechanisms protecting the host. Perforin and granzymes are necessary for proper viral clearance, but at the same time they induce the activation of apoptotic processes. The entry of perforin and granzymes into target cells is a pivotal step for initiating apoptosis leading to death of target cardiac cells [23] . Granzymes, and in particular granzyme B, induce cell apoptosis by activating Bid, dephosphorylating Bad, and promoting the release of Cytochrome c from the mitochondria, which ultimately results in caspase-dependent cell death [6, 39] . Perforin mediates cardiomyocyte injury in acute myocarditis caused by CVB3 [34] . It is also known that perforin induces higher mortality and increased myocarditis severity in CVB3-infected mice [10, 12] . CD8 T cells worsen myocarditis scores but reduce myocardial viral titers [13] . Our results therefore suggest that CAP ?/? mice, which develop a strong type I IFN-dependent antiviral response and dampen cytotoxic cells, are subjected to less cardiac tissue injury than CAP -/-mice, which preferentially mount strong cytotoxic antiviral responses. Although CAP -/-hearts and spleens showed reduced viral proliferation at day 4 post CVB3 infection, we conclude that enhanced cytotoxicity renders CAP -/-mice more susceptible to CVB3-induced mortality during the first week after CVB3 inoculation.
Several studies describe perforin-producing lymphocytes in hearts of patients with viral myocarditis and in the hearts of CVB3-infected mice [33, 34, 45] . In addition, blockade of perforin with anti-perforin neutralizing antibodies limits cardiac cell injury in mice with viral myocarditis [12] . In our study, we observed increased expression of both perforin and granzyme B in hearts of CAP -/-CVB3-infected mice compared to CAP ?/? CVB3-infected controls. Interestingly, perforin was higher in spleens of CAP -/-compared to CAP ?/? CVB3-infected mice, while granzyme B showed comparable expression.
At this time point, we cannot explain this observation, but a growing body of evidence points to granzyme B-independent, perforin-mediated cytotoxic mechanisms [14, 37] . Nevertheless, CAP reduces perforin-mediated cell apoptosis in the CVB3-infected heart.
In the present study, we found that CAP was necessary to induce IFN-b production upon MDA5 stimulation, but not upon TLR3, TLR7, and RIG-I activation. Indeed, MDA5, a cytosolic helicase with specificity toward positive double-strand RNA viruses [16] , is one of the preferred targets of invading viruses. RNA viruses escape cellular antiviral responses by cleaving and degrading MDA5, thereby reducing type I IFNs production and increasing myocarditis susceptibility [4, 43] . Here, we found that CAP prevented MDA5 from CVB3-induced degradation. In addition, when CAP was expressed in HeLa cells, which are otherwise unable to produce CAP [47] , MDA5 complexed with CAP after viral infection. We therefore conclude that CAP acts as a stabilizing molecule for MDA5, which in turn enhances antiviral responses against CVB3. Interestingly, in our pulling-down experiments, we observed that CAP complexed with MyD88, but not with other downstream proteins of the MyD88-IRAKs-TRAFs axis. Impaired or depleted MyD88 function results in general reduction of pro-inflammatory cytokine expression upon TLR activation except of TLR3 [1] . Nevertheless, future studies are needed to understand how exactly CAPdependent modulation of MyD88 influences inflammatory cytokine expression.
Aside from antiviral mechanism, invading viruses can take advantage of the cellular structure of the host. Interaction with host transmembrane receptors in the heart, such as CAR and DAF, promotes conformational changes in the capsid of CVB3 that are essential for viral entry and release of viral RNA [7] . Intracellular signals triggered by both receptors include tyrosine kinase Lck, which is used by CVB3 to rearrange host cytoskeleton and thus increase viral entry [21] . Of note, Lck, apart from being target of CVB3, is well-known tyrosine kinase that promotes ZAP-70 recruitment for T cell receptor downstream signalling that activates T cells [38] . In the present study, we observed that CAP neither modified CAR nor Lck expression in the heart, but reduced Lck phosphorylation in splenocytes. By measuring the expression of CD69 and CD44 high , we confirmed that CAP ?/? T cells were less activated and had lower memory/effector capacity than CAP -/-T cells. While reducing migration of cytotoxic CD8
? T and NK cells, CAP also inhibited perforin and granzyme B production after viral infection in vivo and in vitro. Furthermore, transcription factors Eomes and T-bet, which are related to cytotoxicity [11, 40] , were highly expressed in CAP -/-but not in CAP
spleen.
Taken together, we demonstrated for the first time a novel function of CAP as immune modulator in virusinduced cardiac inflammation. Our data show that CAP exerts a broad range of protective effects against (?)ssRNA virus infection, balancing immune responses towards a favourable outcome. CAP supports type I IFNs while reducing detrimental cytotoxic signals. Modulating CAP production might be a potential therapeutic strategy in acute viral myocarditis in the future, in particular to prevent end-stage heart failure.
Materials and methods
Mice, cells, viruses, and plasmids
Six-to eight-week-old CAP -/-male C57BL/6 mice (also known as Sorbs1 -/-mice) were previously described [19] . All animal experiments were conducted in accordance with the Animal Care Committee of the University Health Network of the University of Toronto. Mouse embryonic fibroblasts (MEF) were cultivated using embryos at day 13.5 of gestation. Bone marrow-derived macrophages (BMM) and bone marrow-derived dendritic cells (BMDC) were cultivated as previously described [9, 41] . Mouse neonatal cardiomyocytes (MNC) were cultivated from the ventricles of 1-day-old newborns, digested with tripsin (0.8 mg/ml) and plated for 2 h at 37°C to separate mouse neonatal cardiac fibroblasts (MNF) from MNC, and then cultivated in the presence of BrdU. The cardiovirulent CVB3 (Gauntt strain) has been described previously [20, 36] , the vesicular stomatitis virus (VSV) was a gift of Dr. J. Bell. Viral titration in HeLa cells by standard plaque assay was performed as previously described [20, 36] . FLAG-tagged plasmids encoding CAP and CAP-DSH3 were a kind gift of Dr. Alan Saltiel [5, 47] .
Histology
Cross sections of mouse hearts were hematoxylin and eosin stained as described [26] , and evaluated for cellular infiltrates and necrosis as follows: 0, absence of infiltrating cells or necrosis; 1, limited focal areas of infiltrating cells or necrosis; 2, mild to moderate infiltrating cells or necrosis; 3, moderate infiltrating cells or necrosis; 4, extensive areas with infiltrating cells or necrosis involving the entire examined heart tissue.
Isolation of heart-infiltrating cells and flow cytometry analysis
Hearts were digested using Liberase TM Research Grade (Roche Diagnostics) at a working concentration of 0.08 Wuensch U/ml for 45 min at 37°C. Heart-infiltrating cells were always triple-stained and first gated on live CD45 high lymphocytes plotted on side-scatter/CD45 high cells, acquired with a BD LSR II or a BD FACSCanto II (BD Biosciences), and analysed with FlowJo (Tree Star). Data were acquired until 200,000 events were collected from a live gate, as previously described [41] . 0 -GCGAAGAGTCTATTGAGCTA-3 0 , as previously described [20] .
Elisa
Commercially available VeriKine ELISA kit (PBL Interferon Source) was used to measure IFN-b.
Western blot analysis and immunoprecipitation
Tissue or cell lysates were separated using NuPAGE Novex Bis-Tris gel (Invitrogen), transferred on PVDF membrane (Roche Diagnostic), and then immunoblotted with specific antibodies. Bands were visualized with an ECL chemiluminescent substrate (Luminata Crescendo, Millipore). For immunoprecipitation, Dynabeads Protein G (Invitrogen) were used according to the manufacturer's instructions. FLAG-tagged proteins were immunoprecipitated using anti-DDK Tag (L5) Affinity Gel (Biolegend).
Reagents
High molecular weight (HMW) polyinosinic-polycytidylic acid (polyIC), low molecular weight (LMW) PolyIC, and the imidazoquinoline R848 were purchased from Invivogen. LPS and CpGs were purchased from Sigma.
Histopathology
Cross sections of paraffin-embedded hearts cut at 5 lm were stained with hematoxylin and eosin to evaluate inflammatory infiltrates reflecting myocarditis scores graded from 0 to 4 [25] .
Echocardiography
Transthoracic 2D, M-mode, and Doppler echocardiographic studies were performed with an Acuson Sequoia C256 system equipped with a 15-MHz linear transducer (15L8) (Version 4.0, Acuson Corp) in mice anaesthetized with isoflurane/oxygen (1/100 %). M-mode tracings were recorded through these anterior and posterior LV walls at the papillary muscle level to measure LV end-diastolic dimension (LVEDD) and LV end-systolic dimension (LVESD). LV fractional shortening (FS) was calculated using the formula FS = [(LVEDD -LVESD)/LVEDD] 9 100.
Statistics
Survival rates were analysed by the Kaplan-Meier method, and differences between groups were tested with the logrank test. Normally distributed data were compared using the unpaired two-tailed Student t test. Statistical analysis was conducted using the Prism 5 software (GraphPad Software). All data were expressed as mean ± SD. Differences were considered statistically significant for P \ 0.05.
